In a historic move, the Union government has slashed the Goods and Services Tax (GST) rates for 33 cancer drugs and rare medicines — from 12 to zero per cent. The decision taken by the GST Council, chaired by Finance Minister Nirmala Sitharaman, on Wednesday, rationalised the indirect tax structure, cutting the current four slabs down to two — scrapping the 12 per cent and 28 per cent rates, while retaining the 5 per cent and 18 per cent slabs. Read more
JSA News
- September 26, 2025
H1-B crisis sparks legal scramble for new HR solutions
- September 25, 2025
Large exposure rule begins to squeeze corporate lending
- September 20, 2025
Increase in H-1B visa fees imposed by the USA
- September 16, 2025
Will the IBC Amendment Bill 2025 Deliver Real Reform?
- September 15, 2025